# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 24, "Curr Ther Res Clin Exp .", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasJournal> \"Curr Ther Res Clin Exp .\"."
1, PublicationYear, 25, 29, "2004", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasPublicationYear> \"2004\"."
92, Title, 110, 348, "Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open - angle glaucoma : A prospective , open - label , randomized , two - arm , parallel - group study .", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasTitle> \"Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open - angle glaucoma : A prospective , open - label , randomized , two - arm , parallel - group study .\"."
2, Bimatoprost, 139, 150, "bimatoprost", "", 
3, Timolol, 155, 162, "timolol", "", 
4, IOP, 166, 186, "intraocular pressure", "", 
92869, PulsatileOcularFlow, 191, 218, "pulsatile ocular blood flow", "", 
26991, Primary_OpenAngleGlaucoma, 236, 265, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
37027, Prospective, 270, 281, "prospective", "", 
6, OpenLabel, 284, 296, "open - label", "", 
7, Randomized, 299, 309, "randomized", "", 
8, Parallel, 324, 332, "parallel", "", 
9, Author, 349, 359, "Vetrugno M", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasAuthor> \"Vetrugno M\"."
10, Author, 368, 379, "Cardascia N", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasAuthor> \"Cardascia N\"."
11, Author, 388, 399, "Cantatore F", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasAuthor> \"Cantatore F\"."
12, Author, 408, 417, "Sborgia C", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasAuthor> \"Sborgia C\"."
13, Italy, 536, 541, "Italy", "", "<http://ctro/data#Population_93496> <http://ctro/data#hasCountry> <http://ctro/data#Italy>."
14, Italy, 638, 643, "Italy", "", 
16, IOP, 733, 753, "intraocular pressure", "", 
17, IOP, 756, 759, "IOP", "", 
31420, EndPointDescription, 1011, 1031, "choroidal blood flow", "AdverseEffect", 
18, Bimatoprost, 1034, 1045, "Bimatoprost", "", 
19, IOP, 1108, 1111, "IOP", "", 
20, Timolol, 1196, 1211, "timolol maleate", "", 
111, ObjectiveDescription, 1297, 1521, "The aim of this study was to compare the effects of bimatoprost and timolol on IOP and choroidal blood flow ( as measured using pulsatile ocular blood flow [ pOBF ] ) in patients with primary open - angle glaucoma ( POAG ) .", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasObjectiveDescription> \"The aim of this study was to compare the effects of bimatoprost and timolol on IOP and choroidal blood flow ( as measured using pulsatile ocular blood flow [ pOBF ] ) in patients with primary open - angle glaucoma ( POAG ) .\"."
22, Bimatoprost, 1349, 1360, "bimatoprost", "", 
23, Timolol, 1365, 1372, "timolol", "", 
24, IOP, 1376, 1379, "IOP", "", 
31421, EndPointDescription, 1384, 1404, "choroidal blood flow", "AdverseEffect", 
92870, PulsatileOcularFlow, 1425, 1452, "pulsatile ocular blood flow", "", 
92871, PulsatileOcularFlow, 1455, 1459, "pOBF", "", 
26995, Primary_OpenAngleGlaucoma, 1481, 1510, "primary open - angle glaucoma", "", 
26996, Primary_OpenAngleGlaucoma, 1513, 1517, "POAG", "", 
37028, Prospective, 1537, 1548, "prospective", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
26, OpenLabel, 1551, 1563, "open - label", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
27, Randomized, 1566, 1576, "randomized", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
28, Parallel, 1589, 1597, "parallel", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
117, Glaucoma, 1633, 1641, "Glaucoma", "", 
29, Italy, 1727, 1732, "Italy", "", 
121, Precondition, 1735, 1970, "Patients with POAG having well - controlled IOP ( < 16 mm Hg ) on monotherapy with timolol 0 . 5 % ophthalmic solution ( 2 drops per affected eye BID ) for ≥ 12 months but with a progressive decrease in pOBF during the same time period", "", "<http://ctro/data#Population_93496> <http://ctro/data#hasPrecondition> \"Patients with POAG having well - controlled IOP ( < 16 mm Hg ) on monotherapy with timolol 0 . 5 % ophthalmic solution ( 2 drops per affected eye BID ) for ≥ 12 months but with a progressive decrease in pOBF during the same time period\"."
26997, Primary_OpenAngleGlaucoma, 1749, 1753, "POAG", "", 
34, IOP, 1779, 1782, "IOP", "", 
120, mmHg, 1790, 1795, "mm Hg", "", 
31, Timolol, 1818, 1825, "timolol", "", 
32, DoseValue, 1826, 1831, "0 . 5", "", 
33, Percentage, 1832, 1833, "%", "", 
68, DoseValue, 1856, 1857, "2", "", 
69, Eyedrops, 1858, 1863, "drops", "", 
126, Frequency, 1881, 1884, "BID", "", 
92872, PulsatileOcularFlow, 1938, 1942, "pOBF", "", 
106348, Randomized, 1976, 1984, "randomly", "", 
35, Timolol, 2061, 2068, "timolol", "", "<http://ctro/data#Medication_93505> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
66, DoseValue, 2071, 2072, "2", "", "<http://ctro/data#Medication_93505> <http://ctro/data#hasDoseValue> \"2\"."
65, Eyedrops, 2073, 2078, "drops", "", "<http://ctro/data#Medication_93505> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>."
129, Frequency, 2096, 2099, "BID", "", "<http://ctro/data#Intervention_93512> <http://ctro/data#hasFrequency> \"BID\"."
36, Bimatoprost, 2154, 2165, "bimatoprost", "", "<http://ctro/data#Medication_93518> <http://ctro/data#hasDrug> <http://ctro/data#Bimatoprost>."
37, DoseValue, 2166, 2171, "0 . 3", "", "<http://ctro/data#Medication_93518> <http://ctro/data#hasDoseValue> \"0 . 3\"."
132, Percentage, 2172, 2173, "%", "", "<http://ctro/data#Medication_93518> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
31423, DeliveryMethod, 2174, 2193, "ophthalmic solution", "", "<http://ctro/data#DeliveryMethod_93522> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_93518> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_93522>."
67, DoseValue, 2196, 2197, "2", "", 
38, Eyedrops, 2198, 2203, "drops", "", 
134, Frequency, 2221, 2223, "QD", "", "<http://ctro/data#Intervention_93525> <http://ctro/data#hasFrequency> \"QD\"."
106347, Evening, 2226, 2230, "9 pm", "", 
135, Duration, 2261, 2269, "180 days", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasCTduration> \"180 days\"."
40, IOP, 2272, 2275, "IOP", "", 
92877, PulsatileOcularFlow, 2280, 2284, "pOBF", "", 
42, Timolol, 2331, 2338, "timolol", "", 
31418, TimePoint, 2343, 2351, "baseline", "", 
31419, TimePoint, 2354, 2359, "day 0", "", 
26999, TimePoint, 2378, 2410, "days 15 , 30 , 60 , 90 , and 180", "", 
138, ConjunctivalHyperemia, 2452, 2474, "conjunctival hyperemia", "", 
37031, EndPointDescription, 2477, 2498, "conjunctival papillae", "AdverseEffect", 
37032, Stinging, 2501, 2509, "stinging", "AdverseEffect", 
37033, EndPointDescription, 2512, 2519, "burning", "AdverseEffect", 
37034, EndPointDescription, 2522, 2544, "foreign body sensation", "AdverseEffect", 
37035, EndPointDescription, 2551, 2583, "pigmentation of periorbital skin", "AdverseEffect", 
139, NumberPatientsCT, 2634, 2648, "Thirty - eight", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasNumberPatientsCT> \"Thirty - eight\"."
140, Male, 2677, 2680, "men", "", "<http://ctro/data#Population_93496> <http://ctro/data#hasGender> <http://ctro/data#Male>."
141, Female, 2686, 2691, "women", "", "<http://ctro/data#Population_93496> <http://ctro/data#hasGender> <http://ctro/data#Female>."
142, Mean, 2694, 2698, "mean", "", 
46, AvgAge, 2712, 2718, "51 . 7", "", "<http://ctro/data#Population_93496> <http://ctro/data#hasAvgAge> \"51 . 7\"."
45, NumberPatientsArm, 2737, 2739, "19", "", "<http://ctro/data#Arm_93531> <http://ctro/data#hasNumberPatientsArm> \"19\". <http://ctro/data#Arm_93540> <http://ctro/data#hasNumberPatientsArm> \"19\"."
51, ObservedResult, 2792, 2902, "At 180 - day follow - up in the timolol group , the IOP and the pOBF remained unchanged compared with baseline", "", "<http://ctro/data#Outcome_93559> <http://ctro/data#hasObservedResult> \"At 180 - day follow - up in the timolol group , the IOP and the pOBF remained unchanged compared with baseline\". <http://ctro/data#Outcome_93586> <http://ctro/data#hasObservedResult> \"At 180 - day follow - up in the timolol group , the IOP and the pOBF remained unchanged compared with baseline\"."
27000, TimePoint, 2795, 2804, "180 - day", "", "<http://ctro/data#Outcome_93559> <http://ctro/data#hasTimePoint> \"180 - day\". <http://ctro/data#Outcome_93586> <http://ctro/data#hasTimePoint> \"180 - day\"."
48, Timolol, 2824, 2831, "timolol", "", 
49, IOP, 2844, 2847, "IOP", "", "<http://ctro/data#IOP_93550> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_93549> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_93550>."
92875, PulsatileOcularFlow, 2856, 2860, "pOBF", "", "<http://ctro/data#Endpoint_93554> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PulsatileOcularFlow>."
146, Bimatoprost, 2912, 2923, "bimatoprost", "", 
147, IOP, 2934, 2937, "IOP", "", 
106349, ObservedResult, 2938, 2956, "remained unchanged", "", "<http://ctro/data#Outcome_93613> <http://ctro/data#hasObservedResult> \"remained unchanged\"."
92876, PulsatileOcularFlow, 2965, 2969, "pOBF", "", 
53, RelativeReduction, 2987, 2993, "38 . 9", "", "<http://ctro/data#Outcome_93640> <http://ctro/data#hasRelativeChangeValue> \"38 . 9\"."
54, PValueChangeValue, 3021, 3031, "P < 0 . 01", "", "<http://ctro/data#Outcome_93640> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 01\"."
58, ConjunctivalHyperemia, 3079, 3101, "conjunctival hyperemia", "", 
105204, Ocular_Itching, 3106, 3120, "ocular itching", "", 
55, NumberAffected, 3123, 3124, "5", "", 
151, PercentageAffected, 3136, 3142, "26 . 3", "", 
59, Bimatoprost, 3154, 3165, "bimatoprost", "", 
60, IrisPigmentation, 3178, 3210, "pigmentation of periorbital skin", "", 
61, NumberAffected, 3213, 3214, "2", "", 
154, PercentageAffected, 3226, 3232, "40 . 0", "", 
62, Bimatoprost, 3244, 3255, "bimatoprost", "", 
64, ObservedResult, 3266, 3352, "The incidence of each AE was higher in the bimatoprost group than in the timolol group", "", 
63, PvalueDiff, 3355, 3366, "P = 0 . 008", "", 
169, ConclusionComment, 3385, 3586, "In this population of patients with POAG , bimatoprost was associated with increased pOBF , and the reduction in pOBF associated with timolol was corrected after patients were switched to bimatoprost .", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasConclusionComment> \"In this population of patients with POAG , bimatoprost was associated with increased pOBF , and the reduction in pOBF associated with timolol was corrected after patients were switched to bimatoprost .\"."
27002, Primary_OpenAngleGlaucoma, 3421, 3425, "POAG", "", 
72, Bimatoprost, 3428, 3439, "bimatoprost", "", 
92873, PulsatileOcularFlow, 3470, 3474, "pOBF", "", 
92874, PulsatileOcularFlow, 3498, 3502, "pOBF", "", 
73, Timolol, 3519, 3526, "timolol", "", 
74, Bimatoprost, 3573, 3584, "bimatoprost", "", 
170, ConclusionComment, 3587, 3705, "Bimatoprost was associated with increased choroidal blood flow , beyond the levels recorded before timolol treatment .", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasConclusionComment> \"Bimatoprost was associated with increased choroidal blood flow , beyond the levels recorded before timolol treatment .\"."
78, Bimatoprost, 3587, 3598, "Bimatoprost", "", 
31417, EndPointDescription, 3619, 3649, "increased choroidal blood flow", "AdverseEffect", 
79, Timolol, 3686, 3693, "timolol", "", 
171, ConclusionComment, 3706, 3806, "The decreased IOP level achieved in the timolol group seemed to be improved further by bimatoprost .", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasConclusionComment> \"The decreased IOP level achieved in the timolol group seemed to be improved further by bimatoprost .\"."
85, IOP, 3720, 3723, "IOP", "", 
86, Timolol, 3746, 3753, "timolol", "", 
87, Bimatoprost, 3793, 3804, "bimatoprost", "", 
172, ConclusionComment, 3807, 3972, "Considering the potential efficacy of bimatoprost on IOP and pOBF , we suggest that this new drug may represent a clinical advance in the medical treatment of POAG .", "", "<http://ctro/data#ClinicalTrial_93474> <http://ctro/data#hasConclusionComment> \"Considering the potential efficacy of bimatoprost on IOP and pOBF , we suggest that this new drug may represent a clinical advance in the medical treatment of POAG .\"."
83, Bimatoprost, 3845, 3856, "bimatoprost", "", 
81, IOP, 3860, 3863, "IOP", "", 
92878, PulsatileOcularFlow, 3868, 3872, "pOBF", "", 
27004, Primary_OpenAngleGlaucoma, 3966, 3970, "POAG", "", 
80, PMID, 4049, 4057, "24672097", "", "<http://ctro/data#Publication_93464> <http://ctro/data#hasPMID> \"24672097\"."
